We are live on ! Find out more
NVCR icon

NovoCure
NVCR

295 hedge funds and large institutions have $5.38B invested in NovoCure in 2023 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 86 increasing their positions, 97 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more call options, than puts

Call options by funds: $151M | Put options by funds: $57.8M

4.18% more ownership

Funds ownership: 80.7% → 84.88% (+4.2%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 304 → 295 (-9)

11% less repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 97

13% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 53

13% less capital invested

Capital invested by funds: $6.2B → $5.38B (-$822M)

Holders
295
Holders Change
-9
Holders Change %
-2.96%
% of All Funds
4.7%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
46
Increased
86
Reduced
97
Closed
53
Calls
$151M
Puts
$57.8M
Net Calls
+$93.4M
Net Calls Change
+$153M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$123M
2
Capital World Investors
Capital World Investors
California
+$93.9M
3
BlackRock
BlackRock
New York
+$57.5M
4
State Street
State Street
Massachusetts
+$42.6M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$38.9M

Top Sellers

Rank Fund Capital Flow
1
Fiera Capital (Canada)
Fiera Capital (Canada)
Quebec, Canada
-$24.5M
2
Capital International Investors
Capital International Investors
California
-$24.2M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$20.8M
4
Goldman Sachs
Goldman Sachs
New York
-$9.59M
5
LP
LMR Partners
United Kingdom
-$8.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
IGWM
251
ICA Group Wealth Management
Colorado
$6.01K – – –
IAS
252
IMA Advisory Services
Colorado
$6.01K – – –
TF
253
Tompkins Financial
New York
$6.01K – – –
ATC
254
Adirondack Trust Company
New York
$6.01K – – –
Simplex Trading
255
Simplex Trading
Illinois
$6K -$23.8K -298 -75%
C
256
Covestor
United Kingdom
$6K +$160 +2 +2%
FCG
257
Financial Connections Group
California
$5K +$7.43K +93 New
SIC
258
Salem Investment Counselors
North Carolina
$4.75K – – –
TFA
259
Toth Financial Advisory
Virginia
$4.51K – – –
CFGS
260
Concourse Financial Group Securities
Alabama
$4.51K – – –
PAI
261
Pittenger & Anderson Inc
Nebraska
$4.45K – – –
WAM
262
WFA Asset Management
Wisconsin
$4.21K – – –
HBW
263
Hazlett, Burt & Watson
West Virginia
$4K – – –
2L
264
25 LLC
Missouri
$3.61K +$4.16K +52 New
EARNEST Partners
265
EARNEST Partners
Georgia
$3.49K – – –
RA
266
Rise Advisors
New York
$3.31K – – –
AWM
267
Abound Wealth Management
Tennessee
$3.25K – – –
SS
268
Sunbelt Securities
Texas
$2.74K +$3.76K +47 New
PFBT
269
Parkside Financial Bank & Trust
Missouri
$2.65K -$160 -2 -4%
BC
270
Barrett & Company
Rhode Island
$2.4K – – –
ZB
271
Zions Bancorporation
Utah
$2.23K – – –
TCM
272
Tradewinds Capital Management
Washington
$2.1K – – –
BWM
273
BerganKDV Wealth Management
Minnesota
$2.1K +$2.8K +35 New
RDIA
274
RE Dickinson Investment Advisors
Iowa
$2K – – –
AF
275
Allworth Financial
California
$1.99K -$14.8K -185 -85%
9 10
11
12 13

NVCR Hedge Fund Activity: Q1 2023 in Review

295 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q1 2023, worth a combined $5.38B — down 13% from $6.2B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of NVCR and 46 opened new positions — a net loss of 7 holders — while 97 trimmed existing stakes and 86 added.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $123M. The largest seller was Fiera Capital (Canada), cutting an estimated $24.5M.

  • 295 institutional investors held NovoCure (NVCR) as of Q1 2023, down from 304 in Q4 2022.
  • Funds reported $5.38B of NovoCure stock for Q1 2023, down 13% quarter-over-quarter.
  • 46 funds opened new NovoCure positions in Q1 2023 and 53 closed out, a net change of -7 holders.
  • The largest NovoCure buyer in Q1 2023 was T. Rowe Price Investment Management, an estimated $123M added.
  • The largest NovoCure seller in Q1 2023 was Fiera Capital (Canada), an estimated $24.5M sold.

Based on aggregated 13F filings for Q1 2023.